Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
about
Pseudomyxoma peritonei--a revisit: report of 2 cases and literature reviewSugarbaker procedure for pseudomyxoma peritoneiSecreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.Pseudomyxoma peritonei.Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Pseudomyxoma peritonei: disseminated peritoneal adenomucinosis variantMucinous Borderline Ovarian Tumor in Very Old Aged Postmenopausal WomanMucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review.Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapySignificance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.Aggressive pseudomyxoma peritonei: a case report with an unusual clinical presentation.Clinicopathological features and prognosis of pseudomyxoma peritonei.Low-grade appendiceal neoplasm presenting as a volvulus of the cecum.Clinical presentation of pseudomyxoma peritonei.Pseudomyxoma peritonei diagnosed 19 years after appendicectomy.Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei 7 days after complete tumour removal.Appendiceal adenocarcinoma presenting as venous thromboembolism: an unusual presentation of a rare carcinoma.Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.Pseudomyxoma peritonei: natural history and treatment.Deterministic Role of CEA and MSI Status in Predicting Outcome of CRC Patients: a Perspective Study Amongst Hospital Attending Eastern Indian Populations.Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei.Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).Histologic and Immunohistochemical Alterations Associated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy.Pseudomyxoma pleurii and peritonei secondary to sigmoid colon adenocarcinoma: a rare clinico-pathologico-radiological presentation
P2860
Q21245592-643CF22E-9E3A-486A-995A-EC3520D0E455Q24245207-9C9EA5DF-E590-4974-91BC-2D7C0A73C8B8Q33579251-EFED2748-6560-4B08-A548-91BAA6E55B92Q34391046-BB120AE4-819E-4A11-A49E-3AAC01B903BBQ34391061-5CFAB6C3-A260-418B-830F-F1816E36AE16Q34952261-DF2C62FF-135D-4C39-9D10-EFE649FC9427Q36480479-FBD613AB-E488-4DD5-BFA7-A070B1077DA3Q36638722-EC3765A7-162B-4775-B6FD-8C5BA019EAFDQ36731514-48BD6F54-C096-46B4-A095-4EA3B4A8C4E1Q36758925-5C113B0F-ADDB-4428-9ED3-D183F0B8C1E7Q36792339-D9FE4566-CCE9-4A22-B6D7-551EB23261D0Q37267412-47BB3E01-1386-44FA-B8C9-25C0D9A5CED6Q37353485-F7FD937C-ADD0-4350-9DF1-B6ECFFF21981Q37388412-02B88F3A-3BD0-4D9E-9EE8-170AE224B2BDQ37609117-900780AF-A9AB-4F5F-8DA8-9C71E30A49E1Q37821133-FFC90D82-31BE-4CE8-B2CE-33D889F27D0FQ40939858-FCB136AF-585D-4C17-8435-815C82229C99Q41371585-DA97B7D8-6F6B-4CE2-9E47-4A35BA82DCE6Q41888966-840442A7-8C40-4D47-A474-163912B6E33EQ43588648-880FF42E-75D5-41B7-9114-704ACE9E1EC8Q46643571-518DE174-041A-4A65-B497-8584F432EE56Q48104553-0744AD0F-2667-4A5F-87A2-3FEB7D0EF77BQ50080354-FBB1511D-09E3-402F-946A-8F05CE69443AQ50951335-1A871507-286B-4D5E-8C03-A48CF01B4361Q51211180-455F7CAC-A768-4AAC-9C12-85160252C98DQ53304239-E75C4E69-6FA9-467F-9E67-110ABC80CC6BQ53516654-556C51F4-5643-4016-B56B-B96D2E641883Q58727701-7E15B5C9-65A0-4D37-B4A5-358B82BC7AD1
P2860
Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@ast
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@en
type
label
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@ast
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@en
prefLabel
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@ast
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@en
P2093
P356
P1476
Utility of CEA and CA 19-9 tum ...... elial cancers of the appendix.
@en
P2093
C Pablo Carmignani
Christina E Sugarbaker
David Chang
Paul H Sugarbaker
Regina Hampton
P304
P356
10.1002/JSO.20107
P577
2004-09-01T00:00:00Z